Stay updated on VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page.

Latest updates to the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page now displays Recruiting status and adds the study contact details (Ardaman S. Shergill, MD; email and phone) for the study team, while older status entries such as Pending Amendment and Suspended were removed.SummaryDifference1.0%

- Check13 days agoChange DetectedUpdated last update date to 2025-08-05 and made minor textual edits to the study overview. There are no changes to enrollment, eligibility criteria, or primary/secondary outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedAdditions introduce a funding-status notice and a new version (v3.2.0), while the old version tag (v3.1.0) is removed; the page now communicates current operating status and a software update.SummaryDifference2%

- Check49 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1). A minor UI item, 'Back to Top', was removed.SummaryDifference0.1%

- Check71 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

Stay in the know with updates to VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page.